No Data
Hubei Guangji Pharmaceutical Gets Registration Approval for Febuxostat Tablets; Shares Jump 8%
Express News | Hubei Guangji Pharmaceutical: Obtained the pharmaceutical registration certificate for Febuxostat tablets.
Hubei Guangji Pharmaceutical (000952.SZ) has received the approval notification for the supplemental application of Pharmaceutical Acyclovir hydrochloride tablets.
Hubei Guangji Pharmaceutical (000952.SZ) announced that recently, the company received the approval issued by the National Medical Products Administration for the hydrochloride...
Express News | Hubei Guangji Pharmaceutical: Signed a global strategic cooperation agreement
Express News | Hubei Guangji Pharmaceutical: The wholly-owned subsidiary Guanghua Pharmaceutical plans to increase capital and introduce strategic investors.
Guangji Pharmaceutical: Report for the third quarter of 2024
No Data